These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1734205)

  • 21. Publication is positively skewed.
    Bjorn G
    Nat Med; 2008 Nov; 14(11):1133. PubMed ID: 18989267
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trials in Norway--completion and reporting are not satisfactory].
    Sandaker L; Fjeld B; Reikvam A; Lislevand H; Madsen S
    Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2888-90. PubMed ID: 15550958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An introductory note to CHMP guidelines: choice of the non-inferiority margin and data monitoring committees.
    Brown D; Volkers P; Day S
    Stat Med; 2006 May; 25(10):1623-7. PubMed ID: 16639776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial human trials with an investigational new drug (phase I and 2): planning an management.
    Vaidya AB; Vaidya RA
    J Postgrad Med; 1981 Oct; 27(4):197-213. PubMed ID: 7338825
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug load in clinical trials: a neglected factor.
    Deckers CL; Hekster YA; Keyser A; Meinardi H; Renier WO
    Clin Pharmacol Ther; 1997 Dec; 62(6):592-5. PubMed ID: 9433387
    [No Abstract]   [Full Text] [Related]  

  • 26. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NHMRC Clinical Trials Centre. Advancing research.
    Ray A
    Aust Fam Physician; 1999 Mar; 28(3):205. PubMed ID: 10098295
    [No Abstract]   [Full Text] [Related]  

  • 28. International conference on harmonisation; guidance on statistical principles for clinical trials; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(179):49583-98. PubMed ID: 10185190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ICH harmonized tripartite guideline: Guideline for Good Clinical Practice.
    International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use.
    J Postgrad Med; 2001; 47(1):45-50. PubMed ID: 11590294
    [No Abstract]   [Full Text] [Related]  

  • 30. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug trials in developing countries: the need for ethics.
    Mbuyi-Muamba JM
    World Health Forum; 1993; 14(1):28-9. PubMed ID: 8439366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the project of legislation relative to drug trials "without medical intent"].
    Bastin R
    Bull Acad Natl Med; 1985 Jun; 169(6):881-4. PubMed ID: 3910188
    [No Abstract]   [Full Text] [Related]  

  • 34. Current standards in reported drug trials.
    Reiffenstein RJ; Schiltroth AJ; Todd DM
    Can Med Assoc J; 1968 Dec; 99(23):1134-5. PubMed ID: 4881692
    [No Abstract]   [Full Text] [Related]  

  • 35. Availability of emergency drugs for pharmacists.
    Graham RC
    Can Pharm J; 1981 Jan; 114(1):13-4. PubMed ID: 10317048
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials in an Australian teaching hospital: problems and procedures.
    Berbatis CG
    Aust Health Rev; 1986; 9(2):116-23. PubMed ID: 10279167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An introductory note to the CHMP guidelines: choice of the non-inferiority margin and data monitoring committees by David Brown, Peter Volkers and Simon Day, Statistics in Medicine 2006; 25:1623-1627.
    Stat Med; 2007 Jan; 26(1):230-3; author reply 234-5. PubMed ID: 16900566
    [No Abstract]   [Full Text] [Related]  

  • 38. Many clinical studies may not be dependable.
    Adams KT
    Manag Care; 2014 Oct; 23(10):36-7. PubMed ID: 25942784
    [No Abstract]   [Full Text] [Related]  

  • 39. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

  • 40. Good clinical practice in clinical drug trials--what you need to know.
    Soyebi K; Abosede ; Coker HA; Osuntoki ; Oyibos W; Keri H; Ogunsola S
    Nig Q J Hosp Med; 2008; 18(2):104-12. PubMed ID: 19068563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.